CERT MEXC RealStocks
Own real CERT shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 02:38:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Certara, Inc. (CERT) operates in the SERVICES-PREPACKAGED SOFTWARE sector and is listed on NASDAQ. The stock is currently priced at $11.19, with a market capitalization of $1.74B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $4.45 to $12.61. This page covers its latest market performance, valuation, price trends and company information.
$1.74B | |
$11.02 | |
$11.35 | |
$10.83 | |
$11.06 | |
1.39M | |
2.63M | |
-- | |
$12.61 | |
$4.45 | |
-- | |
2026-09-30 |
Certara, Inc. (CERT) last closed at $11.19 as of 2026-11-19 00:56:00, up 1.18% ($0.13) from the previous close of $11.06.
During the latest regular trading session, CERT traded between $10.83 and $11.35, with a volume of 1.39M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Certara, Inc. (CERT) moved from $12.22 to $11.19, representing a decline of 8.45% ($1.03).
The stock traded between $10.83 and $12.60 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 3.26 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 82.6%
CERT is currently trading at $11.19, placing it 82.6% of the way from its 52-week low of $4.45 to its 52-week high of $12.61. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
| Industry | SERVICES-PREPACKAGED SOFTWARE |
| Employees | 1,576 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Certara, Inc. (CERT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CERT, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CERT shares and USD.
CERT Shares to USD
1.00 CERT shares = 11.187 USD
Calculations are estimates based on the latest available price and are for reference only.